Jane Street’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$619K Buy
+183,283
New +$830K ﹤0.01% 7527
2026
Q1
– Sell
-140,096
Closed -$993K – 12397
2025
Q4
$1.39M Buy
140,096
+10,624
+8% +$96.9K ﹤0.01% 5470
2025
Q3
$860K Buy
+129,472
New +$626K ﹤0.01% 6647
2025
Q1
– Sell
-14,512
Closed -$95.5K – 10122
2024
Q4
$95.5K Sell
14,512
-21,165
-59% -$167K ﹤0.01% 8779
2024
Q3
$323K Buy
35,677
+8,918
+33% +$106K ﹤0.01% 7914
2024
Q2
$429K Sell
26,759
-13,174
-33% -$191K ﹤0.01% 7393
2024
Q1
$626K Buy
39,933
+973
+2% +$15.2K ﹤0.01% 6392
2023
Q4
$523K Buy
+38,960
New +$484K ﹤0.01% 6815

Other funds holding LXEO

Jane Street's LXEO Position: Q3 2026 in Review

Jane Street opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 183,283 shares worth $619K. The stake represents ﹤0.01% of the portfolio and ranks #7527 among its holdings. This is a return to the name: Jane Street previously reported a position in LXEO as recently as Q4 2025.

Jane Street first reported a position in LXEO in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.39M in Q4 2025. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • Jane Street held 183,283 shares of Lexeo Therapeutics worth $619K as of Q3 2026.
  • Lexeo Therapeutics was a new Jane Street position in Q3 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7527 holding.
  • Jane Street first reported a position in Lexeo Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Jane Street's Lexeo Therapeutics position peaked at $1.39M in Q4 2025.
  • 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.